Prostate Cancer
Targeting glutamine dependence with DRP-104 inhibits proliferation and tumor growth of castration-resistant prostate cancer.
December 20, 2023
Impact of COVID-19 pandemic on ambulatory urologic oncology surgeries.
December 19, 2023
MRI-Guided Radiotherapy for Prostate Cancer: Seeing is Believing.
December 19, 2023
Health-related quality of life among prostate cancer survivors with metastatic disease and non-metastatic disease and men without a cancer history in the USA.
December 19, 2023
PSMA-Targeted PET Radiotracer [18F]DCFPyL as an Imaging Biomarker in Inflammatory Bowel Disease.
December 19, 2023
Assessment of Prostate and Bladder Cancer Genomic Biomarkers Using Artificial Intelligence: a Systematic Review.
December 19, 2023
Prostate cancer genetic risk and associated aggressive disease in men of African ancestry.
December 19, 2023
Lantheus and POINT Biopharma Announce Positive Topline Results from Pivotal SPLASH Trial in Metastatic Castration-Resistant Prostate Cancer
December 18, 2023
Incidence trends in prostate cancer among men in the United States from 2000 to 2020 by race and ethnicity, age and tumor stage.
December 18, 2023
Multiparametric bone MRI targeting aides lesion selection for CT-guided sclerotic bone biopsies in metastatic castrate resistant prostate cancer.
December 18, 2023
Descriptive analysis of prostate cancer pathology data from diagnosis and surgery in men from the 45 and Up Study.
December 18, 2023
Prostate-Specific Membrane Antigen-Targeted Therapies for Prostate Cancer: Towards Improving Therapeutic Outcomes.
December 18, 2023
Feasibility of a novel wearable thermal device for management of bothersome hot flashes in patients with prostate cancer.
December 15, 2023
Medium-term follow up of active surveillance for early prostate cancer at a non-academic institution.
December 15, 2023